New shot aims to stop the plague before it starts
Prevention
Ongoing
This early-stage study tests whether a single injection of a new antibody, JST-010, is safe in healthy adults aged 18 to 55. The goal is to prevent pneumonic plague, a rare but serious lung infection. Researchers compare the antibody to a placebo and monitor participants for one …
Phase: PHASE1 • Sponsor: Just-Evotec Biologics • Aim: Prevention
Last updated Jun 27, 2026 12:31 UTC